This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionLast revisionBoth sides next revision | ||
home:arf:timeline [02.14.2019] – [Notes and comments] sallieq | home:arf:timeline [02.14.2019] – [Notes and comments] sallieq | ||
---|---|---|---|
Line 17: | Line 17: | ||
**1999** – Marshall learns that other patients with sarcoidosis who were administered Angiotensin Receptor Blockers (ARBs) often developed a neurological reaction. Marshall starts a sabbatical in early 2001 in order to further investigate this reaction. | **1999** – Marshall learns that other patients with sarcoidosis who were administered Angiotensin Receptor Blockers (ARBs) often developed a neurological reaction. Marshall starts a sabbatical in early 2001 in order to further investigate this reaction. | ||
- | **2001** - Marshall submits paper explaining that sarcoidosis could have a bacterial pathogenesis. Three revisions of the paper are rejected by the journal | + | **2001** - Marshall submits paper explaining that sarcoidosis could have a bacterial pathogenesis. Three revisions of the paper are rejected by the journal |
**2001 March** - The first early adopter, Elaine Emmi, begins the use of an ARB to treat her sarcoidosis. | **2001 March** - The first early adopter, Elaine Emmi, begins the use of an ARB to treat her sarcoidosis. | ||
Line 23: | Line 23: | ||
**2001 December** - Nilsson //et al.// publish article in //Journal of infectious disease// showing that deceased sarcoidosis patients contain the genetic material from // | **2001 December** - Nilsson //et al.// publish article in //Journal of infectious disease// showing that deceased sarcoidosis patients contain the genetic material from // | ||
- | **2002 March** – Marshall registers | + | **2002 March** – Marshall registers |
**2002 May** – Marshall changes to using the ARB olmesartan medoxomil (Benicar). | **2002 May** – Marshall changes to using the ARB olmesartan medoxomil (Benicar). | ||
- | **2002 August** – Trevor Marshall and Frances (Liz) Marshall publish NetPrint, "[[http://clinmed.netprints.org/ | + | **2002 August** – Trevor Marshall and Frances (Liz) Marshall publish NetPrint, "// |
- | **2002 September** – " | + | **2002 September** – //Remission in Sarcoidosis// is published (in summary) at Mercola.com. Later that month, early adopter (and colleague) Belinda Fenter commences pulsed minocycline. |
**2002 December** – Early adopter (and colleague) Meg Mangin commences pulsed tetracycline. | **2002 December** – Early adopter (and colleague) Meg Mangin commences pulsed tetracycline. | ||
Line 37: | Line 37: | ||
| | ||
- | **2003 January** – Mangin changes to minocycline and commences concurrent olmesartan. Fenter also commences using olmesartan. They are joined by Ms. Dale Thurlow, and Marshall' | + | **2003 January** – Mangin changes to minocycline and commences concurrent olmesartan. Fenter also commences using olmesartan. They are joined by Ms. Dale Thurlow, and Marshall' |
**2004 April** – Autoimmunity Research Foundation is founded. | **2004 April** – Autoimmunity Research Foundation is founded. | ||
Line 47: | Line 47: | ||
**2004 July** – Marshall registers [[http:// | **2004 July** – Marshall registers [[http:// | ||
- | **2004 December** - The Journal of the Interregional Clinical-Diagnostic Center, Kazan, Russia, (ISSN: 1726-6149) publishes, in Russian translation, | + | **2004 December** - [[http:// |
**2005 March ** – ARF's ' | **2005 March ** – ARF's ' | ||
- | **2005 June** - Marshall publishes the English text of the Russian paper " | + | **2005 June** - Marshall publishes the English text of the Russian paper "// |
**2005 July** – Marshall files for [[http:// | **2005 July** – Marshall files for [[http:// | ||
Line 87: | Line 87: | ||
===== Notes and comments ===== | ===== Notes and comments ===== | ||
- | broken links | + | //broken links// |
" | " | ||
// | // | ||
+ | [[http:// | ||
+ | [[http:// | ||
+ | [[http:// | ||
+ | " | ||
+ | |||
+ | " | ||
+ | |||
+ | [[http:// | ||